Table 5.
Practice among respondents
| Questions | n (%) |
|---|---|
| 1. Investigations before initiating statin (can choose more than one) | |
| Aspartate aminotransferase (AST) | 344 (73.8) |
| Full blood count | 26 (5.6) |
| Renal profile (electrolyte, urea and creatinine) | 119 (25.5) |
| Fasting blood glucose | 113 (24.2) |
| Alanine aminotransferase (ALT) | 452 (91.2) |
| Creatine kinase | 103 (22.1) |
| 2. If a patient on statin therapy developed unexplained severe muscle symptoms/fatigue. What will you do? | |
| Stop statin and investigate | 313 (68.3) |
| 3. Additional drug after statin failed to achieve target (can choose more than one) | |
| Niacin | 40 (8.6) |
| Ezetimibe | 239 (51.3) |
| Gemfibrozil | 195 (41.8) |
| Fenofibrate | 204 (43.8) |
| Others | 3 (0.6) |
| 4. Do you use cardiovascular risk calculator to calculate cardiovascular risk before initiating statin? (n=463) | |
| Yes | 369 (79.7) |
| No | 94 (20.3) |
Bold indicates correct answer.